
Northway Biologics
Cambridge, MA, United States northwaybiotech.com From their website, Nov 2026
- GMP
Work here? Claim this listing
About
Northway Biotech is a CDMO supporting biologics and advanced therapies from early development through cGMP manufacturing. It works with clients in mammalian, microbial, plasmid DNA, viral vector, and cell therapy programs from sites in Vilnius, Lithuania and Waltham/Boston, USA.
Services
Cell Line & Strain Development
Develops high-producing mammalian cell lines and optimized microbial expression systems.
Cell line development
Process Development (USP & DSP)
Develops and optimizes upstream and downstream processes for scalable manufacturing and technology transfer.
Analytical Development
Develops, qualifies, and validates phase-appropriate analytical methods.
cGMP Manufacturing
Provides cGMP drug substance and drug product manufacturing for clinical and commercial supply.
CDMO: development & manufacturing
Viral Clearance Studies
Performs early and late-phase viral clearance studies to support purification process validation.
Quality & Regulatory CMC Support
Provides integrated QA, QC, and CMC regulatory support from development through commercialization.
Mammalian Biologics Development & Manufacturing
Supports mammalian programs including monoclonal antibodies, bispecific and multispecific antibodies, fusion proteins, and recombinant proteins.
CDMO: development & manufacturing
Microbial Biologics Development & Manufacturing
Supports bacterial and yeast expression systems for recombinant proteins and other microbial-derived biologics.
CDMO: development & manufacturing
3 more services
- pDNA Development & Manufacturing
- Viral Vector Development & Manufacturing
- Cell Therapy Development & Manufacturing
Capabilities
- Assays and studies
- Process development
- Cell therapy
- Analytical development
- Bioreactors
- Antibodies
- CHO
9 more
- Insect cells
- Bispecifics
- Analytical method development
- Method qualification
- Method validation
- Viral clearance studies
- Process characterization
- Process validation
- Purification process validation
- Scale and capacity
- 10 L to 4,000 L working volume mammalian manufacturing lines
- Up to 3,000 L working volume microbial manufacturing
- Up to 1,000 L working volume viral vector manufacturing
- Up to 300 L working volume pDNA manufacturing
- Up to 200 L working volume BSL-3 production capability
- 3 fill & finish lines
- Therapeutic areas
- Biologics
- Gene therapy
- Cell therapy
- Advanced therapies
Instruments and platforms
- BSL-2 laboratories
- BSL-3 laboratory
- Single-use bioreactors
- 3D bioprinting capabilities
Modalities and species
- Modalities
- Antibody
- Bispecific
- ADC
- Viral vector
- Cell therapy
- Recombinant protein
- Plasmid DNA
- Species and models
- CHO
- E. coli
- Bacteria
- Yeast
- Insect cell (S2)
Certifications
As the company states them, with the certificate or registry record where there is one.
GMPSelf-reported
Company
- Type
- CDMO
- Founded
- 2004
- Size
- 51-200 employees
Locations
- Based in
- Cambridge, MA, United States
- Sites
- Vilnius, Lithuania
- Waltham/Boston, USA
- Serves
- Europe, US, worldwide
Public records
- Wikidata
- Q25499288 source